ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2009

MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.

Federico Cappuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.